COVID-19 containment delay in HK raises risk of transmission
An epidemiological study of the first 56 cases of coronavirus disease 2019 (COVID-19) confirmed in Hong Kong reveals a containment delay of 6.5 days from first symptom……
Research Materials on Influenza and Coronaviral Prevention and Treatment
清肺排毒汤治疗新型冠状病毒肺炎机制的网络药理学探讨
Sorry, this entry is only available in 中文.類型: PDF 作者: 赵静 et al. 出處: 中草药 附件: PDF文件
mRNA vaccines — a new era in vaccinology
Sorry, this entry is only available in 中文.類型: PDF 作者: Norbert Pardi et al. 出處: Nature 連結: https://www.nature.com/articles/nrd.2017.243 附件:...
Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study
OBJECTIVES. To investigate the possible benefits and adverse effects of the addition of lopinavir/ritonavir to a standard treatment protocol for the treatment of severe acute respiratory syndrome…….
Antiviral treatment of SARS: can we draw any conclusions?
Now that a novel coronavirus has been well established as the cause of severe acute respiratory syndrome (SARS) it is important to evaluate what we have learned about the antiviral therapy of SARS…….
Ribavirin in the treatment of SARS: A new trick for an old drug?
The dramatic outbreak of severe acute respiratory syndrome (SARS) has led to the use of high-dose intravenous and oral ribavirin in patients affected with this disorder. Ribavirin, a nucleoside analogue with broad antiviral activity…….